Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desferal versus Desphonac in thalassemia
IRCT20130812014333N117Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of deferoxamine in Thalassaemia (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Respiratory status, Digestive complications and 2 more. Started Mar 2019; status: completed.
02
Drugs
deferoxamine
03
Conditions
Thalassaemia
Beyond the preview
Go deeper on IRCT20130812014333N117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N117.